Cheng-Shun Lai

Title: Innovations of Cheng-Shun Lai

Introduction

Cheng-Shun Lai is a notable inventor based in Sinying, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address various health issues. With a total of three patents to his name, Lai's work focuses on creating effective medicinal solutions.

Latest Patents

One of Lai's latest patents is titled "Glycyrrhizinates of morphinan derivatives." This invention provides a pharmaceutically acceptable compound that can be used to manufacture medicaments for treating and preventing cough, alleviating pain, and addressing respiratory, cardiovascular, and liver diseases. Another significant patent is "Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same." This invention discloses novel salts of aporphine compounds that are suitable for treating hyperglycemic diseases and oxidative stress-related conditions.

Career Highlights

Cheng-Shun Lai is associated with Standard Chem. & Pharm. Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work has contributed to advancements in the development of new therapeutic agents.

Collaborations

Lai collaborates with notable colleagues, including Chin-Tsai Fan and Mei-Jung Lin, who contribute to his research and development efforts.

Conclusion

Cheng-Shun Lai's innovative work in pharmaceuticals demonstrates his commitment to improving health outcomes through scientific advancements. His patents reflect a dedication to addressing critical medical challenges.